Welcome to our dedicated page for Preferred Commer news (Ticker: CELV), a resource for investors and traders seeking the latest updates and insights on Preferred Commer stock.
Overview
Cellev8 Nutrition Inc, formerly known as Preferred Commerce, redefines the nutraceutical landscape with its pioneering approach to SOD-based supplements and advanced delivery systems. As a U.S.-based company, it specializes in harnessing the benefits of superoxide dismutase (SOD) to promote cellular health, reduce oxidative stress, and support overall wellness. By leveraging patent‐pending technology, Cellev8 transforms complex antioxidant research into a range of innovative gummy supplements.
Core Business and Technological Innovation
The company has established itself as a unique player in the wellness market by focusing on proprietary delivery mechanisms that ensure enhanced bioavailability of active ingredients. Its formulations are engineered to support mitochondrial function, promote efficient nutrient absorption, and provide targeted support to athletes and health-conscious consumers alike. With a consistent emphasis on scientific validation and clinical research, Cellev8’s products are developed to deliver comprehensive cellular protection and counteract the effects of oxidative stress.
Product Lines and Market Position
Cellev8 Nutrition’s portfolio includes nutraceutical products designed for various health outcomes such as inflammation reduction, enhanced recovery, and support for cognitive and physical performance. Utilizing advanced delivery systems, the company’s product offerings are optimized to supply critical antioxidants in a user-friendly gummy format. These products have been embraced by diverse consumer segments, ranging from professional athletes to everyday individuals seeking improved health and vitality.
Industry Integration and Strategic Partnerships
Cellev8 has cemented a strong market presence through strategic alliances with reputable entities across the health and wellness sectors. Its collaborations extend across professional sports teams and prominent retail platforms, underscoring a comprehensive approach to market penetration. The company’s emphasis on rigorous scientific research and adherence to regulatory standards further strengthens its credibility within the competitive nutraceutical market.
Operational Excellence and Development
The operational framework of Cellev8 Nutrition is built on methodical research, clinical validations, and iterative product enhancements. The integration of advisory board experts and seasoned professionals in functional medicine and nutrition demonstrates its commitment to excellence and authoritative innovation. By continually refining its formulations and expanding its product range, Cellev8 ensures that its offerings remain aligned with evolving consumer needs and scientific advancements in cellular health.
Commitment to Quality and Regulatory Compliance
Maintaining a robust framework for quality assurance and compliance, Cellev8 Nutrition adheres to established protocols in product development. This commitment to excellence is evident in its use of clinical studies and research data to substantiate product claims. Such rigorous standards foster consumer confidence and highlight the company's dedication to building trust and authority within the nutraceutical industry.
Conclusion
In summary, Cellev8 Nutrition Inc stands out in the wellness industry through its groundbreaking approach to delivering SOD-based supplements via unique, patent-pending technology. With a focus on cellular health, scientifically validated formulations, and a network of strategic partnerships, the company offers a comprehensive and credible portfolio that informs and empowers consumers seeking effective, research-backed nutraceutical solutions.
Cellev8 Nutrition (OTC PINK:CELV) has announced a strategic partnership with NFL Hall of Famer Andre Reed, launched during the Super Bowl. The company specializes in advanced natural supplements featuring Superoxide Dismutase (SOD), utilizing a patent-pending soluble fiber-enhanced gummy technology that delivers approximately 140+ units of SOD2 daily.
The partnership launch generated significant exposure, with Reed introducing Cellev8 to influential players and Hall of Famers. The company's product line includes Inflammation & Recovery Gummies, SlimCell Gummies, and the upcoming Elev8 sports nutrition product. Currently, over 40 professional and collegiate teams are purchasing Cellev8's products.
The company operates in the growing wellness supplements market, which is projected to reach $568.75 billion by 2034, with the global gummy supplements market expected to hit $15.88 billion by 2030.
Cellev8 Nutrition has announced an exclusive partnership with NFL Hall of Famer Andre Reed, set to launch at the Super Bowl. The multi-year collaboration aims to promote the benefits of Superoxide Dismutase (SOD) through Cellev8's nutritional products.
The company offers three key products: Slim Cell for weight management and GLP1 support, Focus and Memory for cognitive enhancement, and Inflammation and Recovery for reducing inflammation. These products utilize a patent-pending delivery system that ensures ingredients reach their intended destinations in the body.
The products are designed to optimize cellular function, enhance SOD production, accelerate recovery, reduce oxidative stress, boost energy production, support detoxification, improve sleep quality, and promote long-term wellness. Reed reported personal benefits including reduced headaches, improved joint mobility, and overall body and brain revitalization.
Cellev8 Nutrition Inc (OTC PINK:CELV) has filed two patents at the US Trademark and Patent Office for its innovative supplement delivery systems. The patents focus on enhancing the transport of Superoxide Dismutase (SOD) and other ingredients throughout the body. The patent-pending formulations aim to improve absorption and utilization of key ingredients, particularly in their SOD formulations.
The company's delivery mechanisms have demonstrated effectiveness across thousands of users, targeting oxidative stress reduction and cellular protection. The technology will be applied across Cellev8's product range, including inflammation and recovery, focus and memory, and GLP1 support gummies. The company currently serves thousands of customers, including over 40 professional and collegiate athletic teams, and maintains partnerships with FDA-certified companies.
Cellev8 Nutrition has launched SlimCell™, a revolutionary gummy supplement designed to support post-GLP-1 weight management. The product features clinically proven ingredients including SOD B® and Morosil, along with soluble fibers. Clinical studies showed significant results: 9.5% cellulite reduction in 28 days, 23% decrease in gluteal folds, and 28% reduction in femoral folds after 3 months. The patent-pending formulation works by reducing oxidative stress, enhancing GLP-1 signaling, and providing cellular protection. The product is positioned in the $142 billion weight loss industry, targeting both GLP-1 medication users and individuals seeking natural weight management solutions.
Cellev8 Nutrition (OTC Pink:CELV) and Vivos Therapeutics announced a strategic joint marketing venture to address obstructive sleep apnea (OSA) and oxidative stress. The collaboration combines Vivos' FDA-cleared oral medical devices for treating OSA with Cellev8's SOD2-based nutraceutical gummies.
The venture targets a significant market, with an estimated 80 million American adults and 10 million children affected by sleep apnea, with up to 80% undiagnosed. The partnership aims to provide a comprehensive solution through Cellev8's nutraceutical products, which have shown efficacy in reducing oxidative stress, inflammation, and improving metabolic health in clinical trials.
The collaboration offers a complementary approach where Vivos devices restore airways while Cellev8's products support bodily rejuvenation and recovery from OSA-related damage.
Cellev8 Nutrition Inc (OTC PINK:CELV) has issued a statement retracting previous announcements about entering the CBD/Cannabis industry, clarifying that no agreements were finalized in this sector. The company has instead positioned itself as a pioneer in Superoxide Dismutase (SOD) based supplements, becoming the first to deliver SOD in gummy form commercially. The company serves thousands of customers, including over 40 professional and collegiate athletic teams, focusing on products for inflammation, recovery, focus, and memory support.
Cellev8 Nutrition (formerly Preferred Commerce) announces corporate updates and growth initiatives. The company has completed its name change and hired Fox Rothschild for legal matters and Salberg & Co. for auditing. Their patent-pending technology delivers SOD2 through proprietary Fibersol-enhanced gummies, now used by 40 professional and collegiate sports teams, up from 2 at year start.
The company reports successful partnerships with Amazon, Vitacost, and Walmart online, plus marketing agreements with Zyppah and Vivos, potentially reaching nearly 1,000,000 customers. New products include SlimCell™ for weight management and Elev8™ for sports nutrition. The company has added notable experts to its advisory board, including sports nutritionists from major league teams.
Cellev8 and Zyppah have announced a collaborative sales agreement targeting 90 million Americans affected by snoring. The partnership combines Cellev8's SOD-based inflammation and recovery gummies with Zyppah's anti-snoring devices. The global anti-snoring devices market, valued at $1.52 billion in 2022, is projected to reach $2.65 billion by 2030. Undiagnosed sleep apnea costs the U.S. economy approximately $149.6 billion annually. The joint offering will be available starting November 1, 2024, through both companies' websites with specific discount codes and subscription models.
FAQ
What is the current stock price of Preferred Commer (CELV)?
What is the market cap of Preferred Commer (CELV)?
What is the core focus of Cellev8 Nutrition Inc?
How do Cellev8's products support overall wellness?
What differentiates Cellev8 Nutrition from other supplement companies?
Who are the primary beneficiaries of Cellev8's product offerings?
How does the company ensure the quality and effectiveness of its formulations?
What strategic partnerships enhance Cellev8 Nutrition's market presence?
